In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...

Ozempic, the blockbuster GLP-1 drug that was ... The clinical study was stopped early after reaching positive endpoints sooner than expected, and no new safety risks were identified in this ...

Digital creator and singer Avery got emotional as she opened up about the health complications she has experienced from using Ozempic.